Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Non Small Cell Lung Cancer Stage”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)UnknownNCT04632758
What this trial is testing

Study Comparing WX-0593 to Crizotinib in ALK Positive Non-Small Cell Lung Cancer (NSCLC) Patients

Who this might be right for
Non-small Cell Lung Cancer
Qilu Pharmaceutical Co., Ltd. 292
Early research (Phase 1)Study completedNCT00255489
What this trial is testing

A Phase I Study of ZD1839 and Palliative Thoracic Radiotherapy in Patients With Non-small-cell Lung Cancer

Who this might be right for
Non-small-cell Lung Cancer
AstraZeneca 36
Early research (Phase 1)Study completedNCT03107663
What this trial is testing

⁸⁹Zr-Df-IAB22M2C PET/CT in Patients With Selected Solid Malignancies or Hodgkin's Lymphoma

Who this might be right for
Positron-Emission TomographyImmunomodulationMetastatic Solid Malignancies+1 more
ImaginAb, Inc. 15
Testing effectiveness (Phase 2)Study completedNCT04776447
What this trial is testing

Atezolizumab Plus Induction Chemotherapy Plus CT-radiotherapy. (APOLO)

Who this might be right for
Lung DiseasesCarcinoma, Non-Small-Cell LungStage IIIA Non-small Cell Lung Cancer+4 more
Fundación GECP 38
Testing effectiveness (Phase 2)Looking for participantsNCT01639508
What this trial is testing

Cabozantinib in Patients With RET Fusion-Positive Advanced Non-Small Cell Lung Cancer and Those With Other Genotypes: ROS1 or NTRK Fusions or Increased MET or AXL Activity

Who this might be right for
Non-Small Cell Lung Cancer
Memorial Sloan Kettering Cancer Center 86
Large-scale testing (Phase 3)UnknownNCT04500717
What this trial is testing

Almonertinib Plus Chemotherapy as First-line Treatment in Patients With EGFR Concomitant Tumor Suppressor Gene Mutation

Who this might be right for
Non Small Cell Lung Cancer
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 460
Testing effectiveness (Phase 2)UnknownNCT03646968
What this trial is testing

Study of Anlotinib Combined With Docetaxel in Non-Driver Mutation Non-squamous NSCLC: the Save Study

Who this might be right for
Non-Squamous Non Small Cell Lung Cancer
Yongchang Zhang 43
Early research (Phase 1)Study completedNCT00975182
What this trial is testing

The Safety and Pharmacology of GDC-0941 in Combination With Erlotinib in Patients With Advanced Solid Tumors

Who this might be right for
Non-Squamous Non-Small Cell Lung Cancer, Solid Cancers
Genentech, Inc. 58
Testing effectiveness (Phase 2)UnknownNCT02407366
What this trial is testing

Icotinib With Concurrent Radiotherapy vs. Chemoradiotherapy in Non-small Cell Lung Cancer

Who this might be right for
Non-small Cell Lung Cancer
People's Hospital of Guangxi Zhuang Autonomous Region 80
Very early researchLooking for participantsNCT05493566
What this trial is testing

Low-Dose Interleukin-2 and Pembrolizumab for the Treatment of Stage IV Non-Small Cell Lung Cancer

Who this might be right for
Lung Non-Small Cell CarcinomaStage IV Lung Cancer AJCC v8Stage IVA Lung Cancer AJCC v8+1 more
Emory University 15
Testing effectiveness (Phase 2)Study completedNCT01102231
What this trial is testing

Chemoradiotherapy in Stage III Non-small Cell Lung Cancer (NSCLC)

Who this might be right for
Stage III Non-small Cell Lung Cancer
Intergroupe Francophone de Cancerologie Thoracique 106
Testing effectiveness (Phase 2)Active Not RecruitingNCT05466149
What this trial is testing

Efficacy and Safety of Furmonertinib in Patients With Locally Advanced or Metastatic NSCLC With EGFR Exon 20 Insertion

Who this might be right for
NSCLC
Allist Pharmaceuticals, Inc. 100
Large-scale testing (Phase 3)Study completedNCT00820755
What this trial is testing

Trial With Cetuximab in Maintenance Therapy After Platinum Based Chemotherapy in First Line Treatment of Non-small Cell Lung Cancer (NSCLC)

Who this might be right for
Non-Small Cell Lung Cancer (NSCLC)
Merck KGaA, Darmstadt, Germany 583
Testing effectiveness (Phase 2)UnknownNCT00801385
What this trial is testing

Sorafenib and Erlotinib in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer That Has Not Responded to Chemotherapy

Who this might be right for
Lung Cancer
Yonsei University 47
Testing effectiveness (Phase 2)Ended earlyNCT00526890
What this trial is testing

Carboplatin, Paclitaxel, Selenomethionine, and Radiation Therapy in Treating Patients With Stage III Non-Small Cell Lung Cancer That Cannot Be Removed by Surgery

Who this might be right for
Lung Cancer
Roswell Park Cancer Institute 16
Testing effectiveness (Phase 2)Ended earlyNCT02831933
What this trial is testing

Trial of Radiation and Gene Therapy Before Nivolumab for Metastatic Non-Small Cell Lung Carcinoma and Uveal Melanoma

Who this might be right for
Lung Squamous Cell Carcinoma Stage IVNonsquamous Nonsmall Cell Neoplasm of LungMetastatic Uveal Melanoma
Eric Bernicker, MD 11
Testing effectiveness (Phase 2)Looking for participantsNCT06822543
What this trial is testing

A Single Arm, Phase 2 Study of Datopotamab Deruxtecan, Carboplatin, and Pembrolizumab for Treatment-naive Brain Metastases From NSCLC (Non-small Cell Lung Cancer)

Who this might be right for
Lung CancerNon Small Cell Lung CancerBrain Metastases
Latin American Cooperative Oncology Group 46
Testing effectiveness (Phase 2)Study completedNCT03322540
What this trial is testing

Pembrolizumab Plus Epacadostat vs Pembrolizumab Plus Placebo in Metastatic Non-Small Cell Lung Cancer (KEYNOTE-654-05/ECHO-305-05)

Who this might be right for
Lung Cancer
Incyte Corporation 154
Early research (Phase 1)Study completedNCT04772989
What this trial is testing

Evaluate AB308 in Combination With AB122 in Participants With Advanced Malignancies

Who this might be right for
Advanced Solid TumorNon Small Cell Lung Cancer (NSCLC)Melanoma+7 more
Arcus Biosciences, Inc. 94
Early research (Phase 1)Study completedNCT03184168
What this trial is testing

Single-dose Study of [14C]Lorlatinib (PF-06463922) Metabolism In Healthy Male Volunteers

Who this might be right for
Healthy Volunteers
Pfizer 6
Next Page